• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

White Paper

Strategies to overcome clinical trials complexities

Decentralized trialseCOA
Clinical research has always been complex, but a significant increase in the level of complexity of clinical trials can have a negative impact on study performance. How complex are clinical...

Breaking barriers in pediatric clinical trials: perspectives from two expert clinicians

Pediatric
Interview with Begoña Nafria, Head of the Patient Engagement in Research Department at SJD Research Foundation in Spain, and Vivienne...

Improving the clinical trial journey with technology and system integration

Interoperability
Over the last two decades, the clinical trial landscape has rapidly evolved towards more decentralization and increased use of advanced...

Innovation and Partnerships: The Biotech Perspective

biotechCardiology
In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle...

ePRO data collection: Decision-making for the adoption of a Bring Your Own Device (BYOD) strategy

BYOD
Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic...

Decentralized Clinical Trials
Essential tips to avoid common pitfalls

Scientific advice
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via...

Do we have the right understanding of how patients perceive digital clinical trials?

Patients insights
Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey results conducted by Kayentis in...

BYOD: When, why and how?

BYOD
What are the main characteristics that make BYOD a strong feature for decentralized trials? What are the key factors to...

eCOA back-up strategies

No longer the “what if” situation: today’s reality and eCOA back-up strategies.How to ensure they are adapted? There have always...

eCOA set-up

Project management
How to anticipate eCOA complexities and ensure a successful launch? Setting up a study with eCOA should be straight forward:...

eCOA challenges of long term studies

OncologyProject management
How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites? Using eCOA solutions can bring...
Follow us on social media
Subscribe to our newsletter
You may also like

If Patients Want A Better Quality Of Life, Why Isn’t...

Strategies to overcome clinical trials complexities

Kayentis 2024 Gender Equality Index

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to...

The unquestionable value of electronic Clinical Outcome Assessments (eCOA) in...

Breaking barriers in pediatric clinical trials: perspectives from two expert...

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA